Provided by Tiger Trade Technology Pte. Ltd.

Repligen

170.02
-10.9600-6.06%
Post-market: 170.020.00000.00%17:24 EDT
Volume:1.41M
Turnover:239.87M
Market Cap:9.57B
PE:232.90
High:182.57
Open:180.70
Low:167.42
Close:180.98
52wk High:188.73
52wk Low:100.99
Shares:56.29M
Float Shares:53.32M
Volume Ratio:1.80
T/O Rate:2.64%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.7300
EPS(LYR):0.8600
ROE:1.99%
ROA:1.40%
PB:4.53
PE(LYR):197.70

Loading ...

Repligen CFO Jason K. Garland Sells 530 Common Shares for $79,500

Reuters
·
Jul 18

Repligen to Report Second Quarter 2026 Financial Results

GlobeNewswire
·
Jul 15

Repligen Stock And 2 Dollar Beneficiaries Gaining Attention After Fed Rate Shift

Simply Wall St.
·
Jul 13

Can Repligen (RGEN) Stay Undervalued On Russell Index Removals And Margin Concerns?

Simply Wall St.
·
Jul 10

Should Repligen's (RGEN) Russell Growth Index Removal Require Action From Current Investors?

Simply Wall St.
·
Jul 08

Benchmark Upgrades Repligen to Buy From Hold, Price Target is $185

MT Newswires Live
·
Jul 07

Repligen Corp : Benchmark Raises to Buy from Hold

THOMSON REUTERS
·
Jul 07

Repligen is Maintained at Outperform by Evercore ISI Group

Dow Jones
·
Jul 07

Q/C Technologies Relocates Headquarters to San Francisco, Sets up 4,800-square-foot Photonics Lab

Reuters
·
Jul 03

Biolife attracts takeover interest from Repligen, Bloomberg says

TIPRANKS
·
Jun 27

Repligen CFO Jason K. Garland Disposes of 733 Common Shares Worth $106,285

Reuters
·
Jun 27

Movement Alert|Repligen Corporation Rises 6.57% in Regular Trading, Trading at $147.26

Market Focus
·
Jun 26

Is Q1 Beat And Reaffirmed 2026 Guidance Altering The Investment Case For Repligen (RGEN)?

Simply Wall St.
·
Jun 15

Repligen (RGEN) Stock Valuation After RBC Coverage Resumes And Q1 2026 Beat

Simply Wall St.
·
Jun 14

Analysts Offer Insights on Healthcare Companies: Repligen (RGEN), Vaxcyte (PCVX) and BeOne Medicines (ONC)

TIPRANKS
·
Jun 04

Repligen posts investor presentation outlining bioprocessing growth strategy, margin expansion path

Reuters
·
Jun 04

U.S. RESEARCH ROUNDUP-Aveanna Healthcare, Palo Alto, Ulta Beauty

Reuters
·
Jun 03

Repligen Coverage Assumed by Wolfe Research at Outperform

Dow Jones
·
Jun 02

Repligen assumed with an Outperform at Wolfe Research

TIPRANKS
·
Jun 02

Repligen CEO Loeillot presents at William Blair Growth Stock Conference

Reuters
·
May 22